Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a note issued to investors on Monday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

Ampio Pharmaceuticals stock opened at $0.01 on Monday. The stock has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.01. The company has a market capitalization of $11,400.00, a P/E ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $2.47.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.